• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.

Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.

Details
Files
DOI
10.7892/boris.82046
Publisher DOI
10.1016/j.ijpddr.2015.02.001
PubMed ID
25941626
Abstract
The naphthoquinone buparvaquone is currently the only drug used against theileriosis. Here, the effects of buparvaquone were investigated in vitro and in an experimental mouse model for Neospora caninum infection. In 4-day proliferation assays, buparvaquone efficiently inhibited N. caninum tachyzoite replication (IC50 = 4.9 nM; IC100 = 100 nM). However, in the long term tachyzoites adapted and resumed proliferation in the presence of 100 nM buparvaquone after 20 days of cultivation. Parasiticidal activity was noted after 9 days of culture in 0.5 µM or 6 days in 1 µM buparvaquone. TEM of N. caninum infected fibroblasts treated with 1 µM buparvaquone showed that the drug acted rather slowly, and ultrastructural changes were evident only after 3-5 days of treatment, including severe alterations in the parasite cytoplasm, changes in the composition of the parasitophorous vacuole matrix and a diminished integrity of the vacuole membrane. Treatment of N. caninum infected mice with buparvaquone (100 mg/kg) either by intraperitoneal injection or gavage prevented neosporosis symptoms in 4 out of 6 mice in the intraperitoneally treated group, and in 6 out of 7 mice in the group receiving oral treatment. In the corresponding controls, all 6 mice injected intraperitoneally with corn oil alone died of acute neosporosis, and 4 out of 6 mice died in the orally treated control group. Assessment of infection intensities in the treatment groups showed that, compared to the drug treated groups, the controls showed a significantly higher parasite load in the lungs while cerebral parasite load was higher in the buparvaquone-treated groups. Thus, although buparvaquone did not eliminate the parasites infecting the CNS, the drug represents an interesting lead with the potential to eliminate, or at least diminish, fetal infection during pregnancy.
Date Issued
2015-04
Publication Type
Article
Subject(s)
600 Technology > 630 Agriculture
500 Science > 570 Life sciences; biology
Subjects
Buparvaquone
•
Cerebral infection
•
Electron microscopy
•
Neospora caninum
•
Neosporosis
•
Real time PCR
Language(s)
en
Author(s)
Müller, Heinz Joachim  
Institut für Parasitologie (IPA)  
Aguado Martinez, Adriana  
Institut für Parasitologie (IPA)  
Manser, Vera  
Institut für Parasitologie (IPA)  
Balmer, Verena  
Institut für Parasitologie (IPA)  
Winzer, Pablo Arnold  
Institut für Parasitologie (IPA)  
Ritler, Dominic  
Institut für Parasitologie (IPA)  
Hostettler, Isabel  
Institut für Ökologie und Evolution (IEE)  
Arranz Solis, David  
Institut für Parasitologie (IPA)  
Ortega-Mora, Luis
Hemphill, Andrew  
Institut für Parasitologie (IPA)  
Additional Credits
Institut für Parasitologie (IPA)  
Institut für Ökologie und Evolution (IEE)  
Journal
International journal for parasitology. Drugs and drug resistance
Publisher
Elsevier
ISSN
2211-3207
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 0eaa7c [ 7.08. 11:06]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify